These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 117106)

  • 21. Novel cephalosporins. Modification of the C-4 carboxyl group.
    Jen T; Dienel B; Frazee J; Weisbach J
    J Med Chem; 1972 Nov; 15(11):1172-4. PubMed ID: 4631921
    [No Abstract]   [Full Text] [Related]  

  • 22. Penicillins and cephalosporins from isothiazolylacetic acids.
    Raap R; Micetich RG
    J Med Chem; 1968 Jan; 11(1):70-3. PubMed ID: 4384130
    [No Abstract]   [Full Text] [Related]  

  • 23. Oximes of 3-formylrifamycin SV. Synthesis, antibacterial activity, and other biological properties.
    Cricchio R; Lancini G; Tamborini G; Sensi P
    J Med Chem; 1974 Apr; 17(4):396-403. PubMed ID: 4151507
    [No Abstract]   [Full Text] [Related]  

  • 24. Structure-activity relationships of cephalosporins having a (dimethylisoxazolidinio)vinyl moiety at their 3-position.
    Hara R; Sakamoto K; Hisamichi H; Nagano N
    J Antibiot (Tokyo); 1996 Nov; 49(11):1162-71. PubMed ID: 8982346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of cephapirin and related cephalosporins from 7-(alpha-bromoacetamido)cephalosporanic acid.
    Crast LB; Graham RG; Cheney LC
    J Med Chem; 1973 Dec; 16(12):1413-5. PubMed ID: 4148798
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis and biological activity of benzothiazolo[3,2-a]quinolone antibacterial agents.
    Chu DT; Fernandes PB; Pernet AG
    J Med Chem; 1986 Aug; 29(8):1531-4. PubMed ID: 3090265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activity of sisomicin.
    Rossi A; Branca G; Manzara S; Morace G; Polonelli L; Spagnolo N; Ttonci M
    J Int Med Res; 1978; 6(2):94-101. PubMed ID: 415913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of the Barton photochemical reaction in the synthesis of 1-dethia-3-aza-1-carba-2-oxacephem: a novel agent against resistant pathogenic microorganisms.
    Hakimelahi GH; Li PC; Moosavi-Movahedi AA; Chamani J; Khodarahmi GA; Ly TW; Valiyev F; Leong MK; Hakimelahi S; Shia KS; Chao I
    Org Biomol Chem; 2003 Jul; 1(14):2461-7. PubMed ID: 12956062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
    Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Microbiological study of gentamiycin].
    Chaĭkovskaia SM; Vakulenko NA; Braginskaia PS; Makarova RA
    Antibiotiki; 1975 Oct; 20(10):903-7. PubMed ID: 2095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of a series of parenteral 3'-quaternary ammonium cephalosporins.
    Brown RF; Kinnick MD; Morin JM; Vasileff RT; Counter FT; Davidson EO; Ensminger PW; Eudaly JA; Kasher JS; Katner AS
    J Med Chem; 1990 Aug; 33(8):2114-21. PubMed ID: 2115587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinicobacteriological studies of cephalexin].
    Kawana R; Nakamura K; Yoshida T
    Jpn J Antibiot; 1970 Apr; 23(2):195-8. PubMed ID: 4988651
    [No Abstract]   [Full Text] [Related]  

  • 34. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
    Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New broad-spectrum cephalosporins with anti-pseudomonal activity. I. Synthesis and antibacterial activity of 7 beta-[D-2-[(4-hydroxy-1,5-naphthyridine-3-carbonylamino)- and (4-hydroxypyridine-3-carbonylamino)]-2-(4-hydoxyphenyl)acetamido] cephalosporins.
    Yamada H; Jimpo K; Tobiki H; Komatsu T; Noguchi H; Irie K; Nakagome T
    J Antibiot (Tokyo); 1983 May; 36(5):522-31. PubMed ID: 6409868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Synthesis of (S)-4-amino-2-hydroxybutyryl derivatives of 3',4'-dideoxykanamycin B and their antibacterial activities.
    Kondo S; Iinuma K; Yamamoto H; Ikeda Y; Maeda K
    J Antibiot (Tokyo); 1973 Nov; 26(11):705-7. PubMed ID: 4209533
    [No Abstract]   [Full Text] [Related]  

  • 37. [Microbiological studies on the combination effect of rifampicin and nalidixic acid (author's transl)].
    Ishiyama M; Nakazawa S
    Jpn J Antibiot; 1974 Oct; 27(5):643-52. PubMed ID: 4218271
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
    Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
    [TBL] [